Venous Thromboembolism
Longer endogenous estrogen exposure increases risk of venous thromboembolism
Published in Women's Health Weekly, February 16th, 2006
According to a study from France, "Lifetime estrogen exposure has been related to breast cancer risk, osteoporosis, and cardiovascular disease but data on venous thromboembolism (VTE) risk are limited."
T. Simon and colleagues of INSERM U258 in Villejuif wrote, "Data from a hospital-based case-control study among 608 postmenopausal women (191 with a first episode of idiopathic VTE and 417 age-matched controls) were used to determine whether estrogen exposure, as assessed by age at menopause [classified as early({{<=}}45 years), normal (46-54 years) and late menopause...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Identification of all sentinel nodes may reduce risk of breast cancer recurrence - Gynecological Cancer
Nedaplatin exhibited strong antitumor activity in gynecological carcinomas - Human Papillomavirus
Human papillomavirus in adolescents could lead to genital abnormalities - Obesity
Smoking during early pregnancy increases risk of obesity in young children - Addiction Medicine
Cash for sterilization program for drug and alcohol addicts increases paid incentives to $300 - Adverse Drug Reaction
CYP17 polymorphism may influence tamoxifen-induced hepatic steatosis - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
